Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference
AI Sentiment
Positive
6/10
as of 02-25-2026 4:00pm EST
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 6.0B | IPO Year: | N/A |
| Target Price: | $33.63 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $17.15 - $42.50 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 83.89% | Revenue Growth (next year): | 31.68% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
CAI Breaking Stock News: Dive into CAI Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
6/10
AI Sentiment
Neutral
4/10
AI Sentiment
Highly Positive
8/10
AI Sentiment
Highly Positive
8/10
AI Sentiment
Neutral
4/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Highly Positive
8/10
AI Sentiment
Highly Positive
9/10
See how CAI stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CAI Caris Life Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.